VS Diagnostics

www.vsdiagnostics.com

QUANTITATIVE, EVIDENCE-BASED DIAGNOSTIC TESTING PROTOCOL EMPOWERING YOU TO:  Objectively VALIDATE subjective pain scores. Yes! Based on 3-4 cardiac bio-markers, you can affirm that a patient is truly in Pain.  QUANTIFY the effectiveness of any treatment algorithm---including weight loss, smoking cessation, maintenance medications, interventional pain therapies, physical therapy, medication management, etc. A patient’s cardiac bio-markers will improve as their overall health improves and pain decreases.  MEASURE Physical and Mental Stress and the impact of pain  EVALUATE compliance in treatment plans.  ESTABLISH proper expectations for healing.  IDENTIFY early on-set risk factors for cardiovascular disease, especially for t those patients that are experiencing other co-morbidities in addition to chronic pain.  EXPOSE developing or advancing neuropathies, arterial stiffness, inflammation, etc ……critical in pre/post-op, or procedural protocols.  MITIGATE risk and elevate MIPS/MACRA score  ADD $35-50K/month in NET incremental revenue We look forward to learning more about your practice and sharing more of the VSD message. Message us to learn more and to get your confidential practice evaluation.

Read more

Reach decision makers at VS Diagnostics

Lusha Magic

Free credit every month!

QUANTITATIVE, EVIDENCE-BASED DIAGNOSTIC TESTING PROTOCOL EMPOWERING YOU TO:  Objectively VALIDATE subjective pain scores. Yes! Based on 3-4 cardiac bio-markers, you can affirm that a patient is truly in Pain.  QUANTIFY the effectiveness of any treatment algorithm---including weight loss, smoking cessation, maintenance medications, interventional pain therapies, physical therapy, medication management, etc. A patient’s cardiac bio-markers will improve as their overall health improves and pain decreases.  MEASURE Physical and Mental Stress and the impact of pain  EVALUATE compliance in treatment plans.  ESTABLISH proper expectations for healing.  IDENTIFY early on-set risk factors for cardiovascular disease, especially for t those patients that are experiencing other co-morbidities in addition to chronic pain.  EXPOSE developing or advancing neuropathies, arterial stiffness, inflammation, etc ……critical in pre/post-op, or procedural protocols.  MITIGATE risk and elevate MIPS/MACRA score  ADD $35-50K/month in NET incremental revenue We look forward to learning more about your practice and sharing more of the VSD message. Message us to learn more and to get your confidential practice evaluation.

Read more
icon

Country

icon

State

Wyoming

icon

City (Headquarters)

Cheyenne

icon

Employees

11-50

icon

Founded

2008

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Director , Us Sales / Business Development

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(22)

Reach decision makers at VS Diagnostics

Free credits every month!

My account

Sign up now to uncover all the contact details